IMU

5.08%

6.2¢ imugene limited

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-137

First 137 Last

Share
Profile

Follow
smart spider

922 Posts.

194

08/04/24

22:02

Post #: 73247770
Share

Originally posted by Jase99: ↑

We were told there would be data cuts done for major conferences and there was a data cut in December which went into the abstract; just as we were told would happen.

What we all hope for is that there was another more recent data cut done for the poster presentation which won’t be released to the ASX until Wednesday morning. Until then we don’t know either way so there’s no need to start second guessing before then. However, if there is not updated data for the poster then the fact still remains, they did do a data cut for the conference so really, no one can say nor complain that it didn’t happen.

Neither YF or LC were involved in writing the paper so, I don’t know why anyone would expect either of them to be involved in the presentation at the AACR conference. People need to differentiate between the various roles. Yes, YF initially developed Vaxinia but he’s not actually running the clinical trials. Yes, LC is the Managing Director/CEO of Imugene but she isn’t actually running the clinical trials. The doctors at the hospitals and some support staff within Imugene are the ones with the hands on involvement with the trials and responsible for collecting, collating, analysing and writing up the results of there findings so, it only makes sense that one or more of them would be the ones presenting the findings at medical conferences. However, if CF33 does become the super star most of us hope it does, then for sure it will be YF fronting up to the media to tell the world about what he invented followed by LC telling the world it’s owned by Imugene, because that’s where their roles fit within the big picture.

Expand

Mate i have to compliment you in all honesty. You are a no nonsense straight to the point and a layman's friend kind of a poster. I for one really look forward to your reasoning after every Imu announcement. Please keep up the good work much appreciated. Most importantly your explanation and reasoning is very easy on the eye and brain. Not to mention our trio in outlander, Ben and Davy. Great job fellows keep it going. Highly appreciated.
thanks again,
SS

IMU Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
58 Upvote

1 Great analysis

Reply

Top Stories

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

HLX

Helix investor makes partial takeover bid, proposing board changes

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

There are more pages in this discussion • 168 more messages in this thread...

First 137 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 6.2¢		Change 0.003(5.08%)		Mkt cap ! $455.6M

Open	High	Low	Value	Volume
5.8¢	6.5¢	5.7¢	$1.751M	28.44M

Buyers (Bids)

No.	Vol.	Price($)
6	660964	6.1¢

Sellers (Offers)

Price($)	Vol.	No.
6.2¢	549788	5

View Market Depth

No.	Vol.	Price($)
4	320000	0.061
8	435316	0.060
2	165000	0.059
7	1686333	0.058
6	1100000	0.057

Price($)	Vol.	No.
0.064	100000	1
0.065	428308	6
0.066	1116000	5
0.067	1247888	2
0.068	3350000	5

Last trade - 16.10pm 30/08/2024 (20 minute delay)

IMU (ASX) Chart

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-137

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-137

Top Stories

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News